# ichrogene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ichrogene

- Industry: Biotechnology
- Headquarters: Gyeonggi-do, South Korea
- Website: http://www.ichrogene.co.kr
- Total disclosed funding: $2.7M
- Latest round: Series A (May 3, 2021)
- Investors on record: 1

## About

Based in Yeongtong-gu, South Korea, and founded in 2017, ichrogene Inc operates as a biotechnology company that develops gene big data analysis services which are used to treat chronic disease and cancer. In May 2021, ichrogene, Inc. raised KRW 3 billion in series A funding led by Insight Equity Partners. As of 2021, the company is led by its CEO Shin Young-ah.

The company offers a gene type data analysis comprehensive platform which provides genome analysis and offers predicting services for chronic diseases, cancer, personal characteristics, etc. through genomic big data analysis. The platform is known as iGAPonCloud. It also provides iDNADoctor which is a genetic testing service, iSearchme which is a raw DBA data uploading service, and iCareMe which is an application-based health information provider.

## Funding rounds

- Series A, May 3, 2021, $2.7M — Insight Equity Partners

## Investors

- Insight Equity Partners (https://capitalatlas.ai/funds/insight-equity-partners) — Series A